Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
CRM.WA
SELLREMOVEPZ Cormay S.A. · Technology · Poland · $12M · Avg Vol: $10K/d
PZ Cormay is a micro-cap Polish diagnostics company lacking global scale, competitive moat, and alignment with our high-conviction macro themes.
COMPANY DESCRIPTION
PZ Cormay S.A. is a Polish medical diagnostics company that designs, manufactures, and distributes high-quality clinical chemistry reagents and automated laboratory analyzers. The company boasts a powerful global footprint, exporting its diagnostic solutions to laboratory customers in over 150 countries. Its competitive advantage lies in its proprietary reagent formulations and its ability to offer integrated, cost-effective diagnostic systems to mid-sized laboratories worldwide.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|
| Revenue | 22.7M | 22.9M | 22.0M | 24.5M | 2.6% |
| EPS | 0.01 | -0.02 | -0.01 | -0.02 | — |
| Shares | 84.2M | 84.2M | 84.2M | 84.2M | 0.0% |
| Debt | 1.1M | 1.1M | 1.6M | 1.6M | 13.8% |
| Equity | 17.3M | 16.3M | 14.8M | 13.3M | -8.4% |
| Op CF | -0.4M | -2.3M | -0.8M | -0.7M | — |
| Inv CF | -1.3M | 2.4M | 1.5M | 0.9M | — |
| Fin CF | -0.2M | -0.4M | -73,100 | -0.3M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Technology, ranked by industry match, size, and score similarity. Cross-listings of CRM.WA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| CRM.WA | PZ Cormay S.A.(you) | $12M | 30 | SELL |
| SCW.WA | SCANWAY | $139M | 26 | SELL |
| INL.WA | Introl S.A. | $54M | 99 | STRONG BUY |
| SON.WA | Sonel S.A. | $58M | 97 | STRONG BUY |
| SNX.WA | Sunex S.A. | $16M | 12 | STRONG SELL |
| MLS.WA | ML System S.A. | $29M | 11 | STRONG SELL |
| QNA.WA | QNATECHNO | $34M | 11 | STRONG SELL |
| KOM.WA | Komputronik S.A. | $17M | 65 | HOLD |
| ATD.WA | Atende S.A. | $36M | 51 | HOLD |
| NCL.WA | NOCTILUCA | $53M | 14 | STRONG SELL |
Peer medians: ROE 14.3% · P/E 15.9x · Gross margin 27.2%